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Reply to the Editor:
We appreciate the comments from
Mascitelli and colleagues. We have
shown that preoperative statin use is as-
sociated with lower operative mortality
in cardiac surgical patients without coro-
nary artery disease.1 As they pointed out
and as we described in the original arti-
cle,1 serum cholesterol level could be
a potentially confounding factor of the
association between preoperative statin
use and operative outcomes. However,
the effect of baseline hypocholesterole-
mia on operative outcomes in patients
having cardiac surgery remains un-
known. The previous studies, including
ones that Mascitelli and colleagues refer-
enced, did not reveal an effect. In another
study, Horwich and colleagues2 have
shown that lower serum cholesterol level
at the time of admission is associated
with increased mortality in patients
with heart failure, and that patients with
lower serum cholesterol levels were
more likely to be on lipid-lowering med-
ication. Although the study population
of this study is not patients having sur-
gery, their findings indicate that serum
cholesterol level may be a negative con-
founding factor in our analysis, which
would not affect our conclusion. Further
investigation is necessary to determine
the effect of preoperative statins on oper-
ative outcomes in cardiac surgery.
Minoru Tabata, MD, MPH
Tokyo, Japan
Letters to the EditorDOES
HYPERCHOLESTEROLEMIA
IMPROVE OPERATIVE
OUTCOMES IN PATIENTS
WITHOUT CORONARY
ARTERY DISEASE WHO
UNDERGO CARDIAC
SURGERY?
To the Editor:
Tabata and colleagues1 found that
preoperative use of statins was associ-
ated with lower operative mortality in
patients without coronary artery dis-
ease who underwent cardiac valve sur-
gery and suggested that the pleiotropic256 The Journal of Thoracic aneffects of statins may be an important
biological mechanism underlying this
beneficial effect.
Although the authors did not include
preoperative serum cholesterol levels
in the analysis because they were not
measured in all patients, they specu-
lated that a beneficial effect of a de-
creased serum cholesterol might not
be ruled out.1 However, the study
suggests that higher baseline choles-
terol levels might actually improve
operative outcomes in patients without
coronary artery disease who undergo
cardiac surgery. In fact, baseline total
cholesterol levels of statin-treated pop-
ulations are higher than those of the
general population.2
Critical care literature provides
strong evidence for a survival advan-
tage associated with higher lipid
levels in critically ill surgical patients.3
Furthermore, in surgical patients,
hypocholesterolemia, beyond being
a strong predictor of in-hospital death,
also predicts nosocomial infections
and length of hospital stay.4 In particu-
lar, it has been shown that critically low
cholesterol concentrations in patients
after cardiothoracic surgery are associ-
ated with a significantly increased risk
for mortal outcome.5
Therefore, we suggest that in indi-
viduals studied by Tabata and col-
leagues,1 statin use selected the
healthy statin user or unselected the
unhealthy patients with low choles-
terol.
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